$169/mo
Tirzepatide
Weekly and dual-action. Care, coaching and shipping included.
Get startedHome / Hims alternatives
Hims is a solid choice for brand-name GLP-1s, and it isn't the right fit for everyone. If the membership, the brand-name price or state availability is why you're looking, here are three alternatives, what each costs all in, and who each one suits. We're one of them, so we show our work.
Hims vs NexLife
| Provider | All in, to start |
|---|---|
| Hims | $448 tirzepatide $298 semaglutide |
| NexLife | $169 tirzepatide $139 semaglutide |
Takes a few minutes online. A licensed provider decides if treatment is right for you.
4.8 out of 5 on Trustpilot
Your medication and dose, the date of your last dose, and your prescription label or a recent receipt.
They check your history and current dose and, when appropriate, continue it.
The same price at every dose, with care, coaching and shipping included.
NexLife publishes this page and is one of the alternatives on it. That's why every price is sourced, the brand-name options are listed with their prices, and the case for staying with Hims is made in plain words.
The best Hims alternative depends on why you're switching. For the lowest all-in price, NexLife: compounded tirzepatide at $169 a month and semaglutide at $139, the same at every dose with no membership. At Hims, brand-name Zepbound starts at $448 a month and Wegovy at $298, including its $149 monthly membership. If insurance might cover brand-name medication, Ro's concierge handles the paperwork. If you want the FDA-approved product, stay with brand-name: compounded medications aren't FDA-approved.
The reasons we hear most, with the numbers behind them.
| Provider | What you get | All in, to start |
|---|---|---|
| Hims (now) | Brand-name Zepbound or Wegovy (pen or pill). Includes a $149 monthly membership | $448 tirzepatide $298 semaglutide |
| NexLife | Compounded tirzepatide or semaglutide. No membership; the same price at every dose | $169 tirzepatide $139 semaglutide |
| Ro | Brand-name Zepbound or Wegovy at the manufacturer's price, plus a $149 monthly membership; rises with the dose | $448 to $598 tirzepatide $348 to $498 semaglutide |
| Mochi | Compounded, with brand-name options. Includes a $79 monthly membership; medication priced by dose | $169 tirzepatide $139 semaglutide, to start |
Month-to-month prices from each provider's own website, checked September 24, 2026, memberships included. See the GLP-1 price index for every plan.
Ranked by all-in monthly price, then by what's included.
Compounded tirzepatide at $169 a month and semaglutide at $139, all in, with no membership, where Hims adds a $149 monthly membership to the medication. Available in all 50 states. Compounded, so not FDA-approved.
The same brand-name medications Hims offers, plus a concierge that checks your coverage and handles the paperwork. Paying cash: $448 to $598 a month for Zepbound, $348 to $498 for Wegovy.
Board-certified obesity medicine doctors you choose, plus registered dietitians. Compounded tirzepatide from $169 and semaglutide from $139 to start, including a $79 monthly membership, with the medication priced by dose.
Switching isn't always the right move. Stay if:
Whatever you choose, a licensed provider should review your history and dose before anything changes.
Keep following your Hims prescription until your new provider confirms your next step.
Your medication and dose, the date of your last dose, and your prescription label or a recent receipt.
A NexLife provider looks at your dose and how you're tolerating it and, when appropriate, continues it.
Moving between brand-name and compounded medication is a change of product. Compounded medication isn't FDA-approved, and your provider will walk you through it.
Paying less than NexLife for compounded medication somewhere else? See how our price match works.
Both are prepared by U.S.-licensed 503A pharmacies, lab-tested batch by batch and shipped free. Your provider helps you decide which one fits.
$169/mo
Weekly and dual-action. Care, coaching and shipping included.
Get started$139/mo
Weekly GLP-1. Care, coaching and shipping included.
Get startedPrescription required. Compounded medications are not FDA-approved. On 12-month plans: $139 a month for tirzepatide, $119 for semaglutide, still the same at every dose.
No membership, no dose surcharges, no surprises. One flat, all-inclusive monthly price at every dose.
| Month one | Month two | Month three | Every month after | |
|---|---|---|---|---|
| Tirzepatide | $169 | $169 | $169 | $169 |
| Semaglutide | $139 | $139 | $139 | $139 |
Month-to-month plan, all-inclusive. Longer plans cost less and stay flat: $159, $149 and $139 a month for tirzepatide on 3-, 6- and 12-month plans; $132, $125 and $119 for semaglutide.
Tap where you are now. We'll show your NexLife price next to it.
Pick one above to see your price.
Prices from each provider's website, checked September 24, 2026. Brand-name and compounded medications are different products; compounded medications are not FDA-approved. †Price match terms apply.
Switching from another provider? If you take compounded tirzepatide or semaglutide somewhere else, we'll match the monthly price you pay today, all in.† You keep your price, and gain a provider who follows your dose, a personal nutrition plan, a 1:1 coaching call and support 24/7.
Switch with confidencePrice matched in writingCancel anytime
†NexLife Price Match Guarantee: for new members switching from a licensed U.S. telehealth provider with an active prescription for compounded tirzepatide or semaglutide. Send a receipt from the last 60 days and we match your regular all-in monthly price (medication plus required fees), not first-month offers or coupons, for as long as your membership stays active. A NexLife provider must determine that treatment is right for you. Full terms.
The best Hims alternative depends on why you're switching. For the lowest all-in price, NexLife: compounded tirzepatide at $169 a month and semaglutide at $139, the same at every dose with no membership. At Hims, brand-name Zepbound starts at $448 a month and Wegovy at $298, including its $149 monthly membership. If insurance might cover brand-name medication, Ro's concierge handles the paperwork. If you want the FDA-approved product, stay with brand-name: compounded medications aren't FDA-approved.
Yes. At NexLife, compounded tirzepatide is $169 a month and semaglutide $139, all in, at every dose. At Hims, brand-name Zepbound starts at $448 and Wegovy at $298, membership included. The difference is also the product: Hims prescribes FDA-approved brand-name medication, and compounded medication isn't FDA-approved.
$149 a month after a $39 first month, billed on top of the medication, according to its site when we checked on September 24, 2026.
Yes. Start an assessment and share your current prescription and dose. A NexLife provider reviews it and, when appropriate, continues your dose rather than restarting you. Moving from brand-name to compounded is a change of product, so your provider will explain what's different.
No. Zepbound is the FDA-approved medicine made by Eli Lilly. Compounded tirzepatide is prepared by a licensed pharmacy for an individual patient; it isn't FDA-approved, and the FDA hasn't reviewed it for safety, effectiveness or quality.
The price match covers compounded medication. Hims prescribes brand-name medication, which costs more than NexLife's flat price, so switching already lowers your monthly bill: $169 instead of $448 or more for tirzepatide, and $139 instead of $298 or more for semaglutide.
Ro. Its concierge checks your coverage for brand-name Zepbound or Wegovy and handles the paperwork. Compounded medication, including NexLife's, is almost never covered, although HSA and FSA funds usually work.
Its site says it isn't available in all 50 states. NexLife serves patients in all 50 states.
No. A licensed provider reviews your health history and prescribes only if treatment is appropriate for you. Not everyone who applies is prescribed, and that's how it should be.
Compounded tirzepatide and semaglutide are not FDA-approved. The FDA has not reviewed them for safety, effectiveness or quality. The risks below come from the labeling of the FDA-approved medicines.
Both medicines may cause tumors in the thyroid, including thyroid cancer. In studies with rodents they caused thyroid tumors, and it isn't known whether they cause them in people. Don't use either if you or anyone in your family has had medullary thyroid carcinoma (MTC), or if you have multiple endocrine neoplasia syndrome type 2 (MEN 2). Tell your clinician if you notice a lump or swelling in your neck, hoarseness, trouble swallowing or shortness of breath.
Serious side effects can include inflammation of the pancreas (pancreatitis), gallbladder problems, low blood sugar (especially with insulin or sulfonylureas), kidney problems from dehydration, severe stomach problems, serious allergic reactions, vision changes in people with type 2 diabetes, and depression or thoughts of suicide. Tell your care team before any surgery or procedure that uses anesthesia or deep sedation. Don't combine either medicine with other GLP-1 medicines.
Tirzepatide can make birth control pills less effective: use another method for 4 weeks after you start and after each dose increase. Semaglutide should be stopped at least 2 months before a planned pregnancy. Tell your clinician if you're pregnant, planning to be, or breastfeeding.
This is a summary, not the complete safety information. Read the full Prescribing Information for FDA-approved tirzepatide (Zepbound) and semaglutide (Wegovy), and talk with your clinician. You can report side effects to the FDA at 1-800-FDA-1088 or fda.gov/medwatch.
A comparison is only as good as the people who stand behind it. Here's who checked this page, and the rules we hold ourselves to.
Medically reviewed this page on September 24, 2026.
Checked every provider's own pricing page on September 24, 2026. Sources are linked at the bottom of this page.
Start with a few minutes online. A licensed provider reviews your current dose and history and takes it from there.
Backed by our guarantee. Follow your plan for six months as prescribed. If you lose less than 5% of your starting weight, you can request a refund of program fees. Medication costs aren't refundable. See the conditions.
A short online health assessment. It takes a few minutes.
You're prescribed only if treatment is right for you.
Free expedited shipping, typically 1 to 2 business days, and 24/7 support from there.
The facts in one place, as of September 24, 2026.
More from NexLife: Ro alternatives · Mochi alternatives · best tirzepatide providers · best semaglutide providers · switching providers, price matched
Physician-led, LegitScript-certified telehealth for GLP-1 weight loss. One flat price at every dose, and support 24/7.
© 2026 NexLife. Prescription treatment requires an online evaluation by a licensed provider, and not everyone qualifies. Compounded medications are not FDA-approved. This site does not provide medical advice.